Par Drugs & Chemicals Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2025 is 2.37% vs 10.02% in Sep 2025

Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 16.22% vs 24.02% in Sep 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is -0.16% vs 70.51% in Sep 2025

Interest

QoQ Growth in quarter ended Dec 2025 is -80.00% vs 150.00% in Sep 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Par Drugs & Che. With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

29.34

262.72

-233.38

-88.83%

Other Operating Income

0.00

Total Operating income

29.34

262.72

-233.38

-88.83%

Raw Material Cost

12.12

229.40

-217.28

-94.72%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.27

-10.74

11.01

102.51%

Employee Cost

1.41

8.95

-7.54

-84.25%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

9.48

31.71

-22.23

-70.10%

Total Expenditure (Excl Depreciation)

23.28

259.32

-236.04

-91.02%

Operating Profit (PBDIT) excl Other Income

6.06

3.40

2.66

78.24%

Other Income

1.33

0.14

1.19

850.00%

Operating Profit (PBDIT)

7.39

3.54

3.85

108.76%

Interest

0.01

0.05

-0.04

-80.00%

Exceptional Items

0.00

Gross Profit (PBDT)

7.38

3.49

3.89

111.46%

Depreciation

0.93

1.39

-0.46

-33.09%

Profit Before Tax

6.44

2.12

4.32

203.77%

Tax

1.64

0.53

1.11

209.43%

Provisions and contingencies

0.00

Profit After Tax

4.80

1.58

3.22

203.80%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

4.80

1.58

3.22

203.80%

Equity Capital

12.30

8.88

3.42

38.51%

Face Value

10.00

0.00

Reserves

98.83

0.00

98.83

Earnings per share (EPS)

3.90

1.78

2.12

119.10%

Diluted Earnings per share

3.90

1.78

2.12

119.10%

Operating Profit Margin (Excl OI)

20.65%

1.29%

0.00

19.36%

Gross Profit Margin

25.15%

1.33%

0.00

23.82%

PAT Margin

16.36%

0.60%

0.00

15.76%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 29.34 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 2.37% vs 10.02% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 37.23% vs -10.92% in Dec 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 4.80 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is 16.22% vs 24.02% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 727.59% vs -83.04% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 6.06 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -0.16% vs 70.51% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 326.76% vs -72.85% in Dec 2024

Quarterly - Interest

Interest 0.01 Cr

in Dec 2025

Figures in Cr

QoQ Growth in quarter ended Dec 2025 is -80.00% vs 150.00% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 0.00% vs -50.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 20.65%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024